These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 26972575)

  • 1. Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's disease.
    Fichna M; Rogowicz-Frontczak A; Żurawek M; Fichna P; Gryczyńska M; Zozulińska-Ziółkiewicz D; Ruchała M
    Endocrine; 2016 Jul; 53(1):249-57. PubMed ID: 26972575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes.
    Brorsson C; Vaziri-Sani F; Bergholdt R; Eising S; Nilsson A; Svensson J; Lernmark Å; Pociot F;
    Autoimmunity; 2011 Mar; 44(2):107-14. PubMed ID: 20836749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
    Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
    Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-ZnT8 autoantibodies: A new marker to be screened in patients with anti-adrenal antibodies.
    Bost C; Jordan T; Magali D; Françoise F; Nicole F
    Clin Chim Acta; 2020 Dec; 511():1-6. PubMed ID: 32946793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of ZnT8 antibody in relation to phenotype and SLC30A8 polymorphism in adult autoimmune diabetes: results from the HUNT study, Norway.
    Sørgjerd EP; Skorpen F; Kvaløy K; Midthjell K; Grill V
    Autoimmunity; 2013 Feb; 46(1):74-9. PubMed ID: 23061550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes.
    Salonen KM; Ryhänen S; Härkönen T; Ilonen J; Knip M;
    Diabetes Metab Res Rev; 2013 Nov; 29(8):646-54. PubMed ID: 23861236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes.
    Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kuwahara H; Kobayashi M; Abiru N; Yamasaki H; Eguchi K
    J Clin Endocrinol Metab; 2010 Feb; 95(2):707-13. PubMed ID: 20061424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are zinc transporter type 8 antibodies a marker of autoimmune thyroiditis in non-obese adults with new-onset diabetes?
    Rogowicz-Frontczak A; Zozuliłska-Ziołkiewicz D; Litwinowicz M; Niedźwiecki P; Wyka K; Wierusz-Wysocka B
    Eur J Endocrinol; 2014 Apr; 170(4):651-8. PubMed ID: 24480135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc transporter type 8 autoantibodies (ZnT8A): prevalence and phenotypic associations in latent autoimmune diabetes patients and patients with adult onset type 1 diabetes.
    Andersen MK; Härkönen T; Forsblom C; Groop PH; Knip M; Tuomi T
    Autoimmunity; 2013 Jun; 46(4):251-8. PubMed ID: 23194113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype.
    Trabucchi A; Faccinetti NI; Guerra LL; Puchulu FM; Frechtel GD; Poskus E; Valdez SN
    Autoimmunity; 2012 Mar; 45(2):137-42. PubMed ID: 21875382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
    Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
    Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
    Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
    Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects.
    Wenzlau JM; Walter M; Gardner TJ; Frisch LM; Yu L; Eisenbarth GS; Ziegler AG; Davidson HW; Hutton JC
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4712-9. PubMed ID: 20610599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of zinc transporter 8 (ZnT8) antibodies in autoimmune diabetic patients from Argentinian population using monomeric, homodimeric, and heterodimeric ZnT8 antigen variants.
    Faccinetti NI; Guerra LL; Penas Steinhardt A; Iacono RF; Frechtel GD; Trifone L; Poskus E; Trabucchi A; Valdez SN
    Eur J Endocrinol; 2016 Feb; 174(2):157-65. PubMed ID: 26567119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.
    Wenzlau JM; Juhl K; Yu L; Moua O; Sarkar SA; Gottlieb P; Rewers M; Eisenbarth GS; Jensen J; Davidson HW; Hutton JC
    Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17040-5. PubMed ID: 17942684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc transporter 8 autoantibodies assessment in daily practice.
    Hussein H; Ibrahim F; Sobngwi E; Gautier JF; Boudou P
    Clin Biochem; 2017 Jan; 50(1-2):94-96. PubMed ID: 27363941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk.
    Achenbach P; Lampasona V; Landherr U; Koczwara K; Krause S; Grallert H; Winkler C; Pflüger M; Illig T; Bonifacio E; Ziegler AG
    Diabetologia; 2009 Sep; 52(9):1881-8. PubMed ID: 19590848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Zinc Transporter 8 Autoantibodies Following Type 1 Diabetes Onset: The Type 1 Diabetes Genetics Consortium Autoantibody Workshop.
    Wenzlau JM; Frisch LM; Hutton JC; Fain PR; Davidson HW
    Diabetes Care; 2015 Oct; 38 Suppl 2(Suppl 2):S14-20. PubMed ID: 26405067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes.
    Vaziri-Sani F; Delli AJ; Elding-Larsson H; Lindblad B; Carlsson A; Forsander G; Ivarsson SA; Ludvigsson J; Marcus C; Lernmark Å
    J Immunol Methods; 2011 Aug; 371(1-2):25-37. PubMed ID: 21708156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of ZnT8 autoantibodies in the diagnosis of autoimmune diabetes in a large French cohort.
    Garnier L; Marchand L; Benoit M; Nicolino M; Bendelac N; Wright C; Moulin P; Lombard C; Thivolet C; Fabien N
    Clin Chim Acta; 2018 Mar; 478():162-165. PubMed ID: 29288641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.